9-Sep-2026 - The Globe and Mail Revvity (RVTY) Receives a New Rating from UBS In a report released yesterday, from UBS initiated coverage with a Hold rating on Revvity and a price target of $140.00. The company’s shares closed yesterday at $127.08. In addition to UBS, Revvity ...
9-Sep-2026 - The Globe and Mail Bernstein Keeps Their Hold Rating on Revvity (RVTY) In a report released today, Eve Burstein from Bernstein maintained a Hold rating on Revvity, with a price target of $120.00. Burstein covers the Healthcare sector, focusing on stocks such as Agilent, ...
8-Sep-2026 - Yahoo Finance Revvity to Acquire Human Cell Design Revvity (RVTY) has agreed to acquire Human Cell Design (HCD), the company said Wednesday. Financial terms were not disclosed. The acquisition is expected to bolster Revvity's Life ...
6-Sep-2026 - The Globe and Mail KeyBanc Sticks to Their Buy Rating for Revvity (RVTY) In a report released today, from KeyBanc maintained a Buy rating on Revvity, with a price target of $165.00. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for ...
24-Aug-2026 - Zacks Investment Research Is the options market predicting a spike in Revvity stock? Investors in Revvity, Inc. RVTY need to pay close attention to the stock based on moves in the options market lately. That is because the Sept. 18, 2026 $50 Put had some of the highest implied ...
Latest RVTY Trades by Congress Members
4-MAY-2026 - Gilbert Cisneros, CA (District 31) purchased between $15,001 and $50,000.
9-Sep-2026 - The Globe and Mail Revvity (RVTY) Receives a New Rating from UBS In a report released yesterday, from UBS initiated coverage with a Hold rating on Revvity and a price target of $140.00. The company’s shares closed yesterday at $127.08. In addition to UBS, Revvity ...
9-Sep-2026 - The Globe and Mail Bernstein Keeps Their Hold Rating on Revvity (RVTY) In a report released today, Eve Burstein from Bernstein maintained a Hold rating on Revvity, with a price target of $120.00. Burstein covers the Healthcare sector, focusing on stocks such as Agilent, ...
8-Sep-2026 - Yahoo Finance Revvity to Acquire Human Cell Design Revvity (RVTY) has agreed to acquire Human Cell Design (HCD), the company said Wednesday. Financial terms were not disclosed. The acquisition is expected to bolster Revvity's Life ...
6-Sep-2026 - The Globe and Mail KeyBanc Sticks to Their Buy Rating for Revvity (RVTY) In a report released today, from KeyBanc maintained a Buy rating on Revvity, with a price target of $165.00. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for ...
24-Aug-2026 - Zacks Investment Research Is the options market predicting a spike in Revvity stock? Investors in Revvity, Inc. RVTY need to pay close attention to the stock based on moves in the options market lately. That is because the Sept. 18, 2026 $50 Put had some of the highest implied ...
